Akston Biosciences
Beverly
About Akston Biosciences
Akston Biosciences Corporation leverages its novel fusion protein platform to develop and manufacture new classes of biologics, including vaccines, ultra-long-acting insulins, and autoimmune disease therapies. It was founded in 2011 and headquartered in Beverly, Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $46.6M
- Funding stage: Late Stage Venture
- Last round: Series H (Apr 2025)
- Website: akstonbio.com
- Phone: 978-969-3381
Industries & Categories
Biopharma, Biotechnology, Diabetes, Veterinary
Social Profiles
Canonical: https://fsome.com/organization/akston-biosciences-48190 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.